万维提示：
1、投稿方式：在线投稿。
2、刊内网址（202502期）：
https://journals.lww.com/gscm/pages/default.aspx
3、投稿系统：
https://www2.cloud.editorialmanager.com/gscm/default2.aspx
4、刊内电话：010-64089043
5、刊内邮箱：GSCM2023@126.com
6、出刊日期：季刊，逢季末月出版。
7、官方微信公众号：中医规范与标准
8、官网信息：不收版面费审稿费。
2025年7月17日星期四
Instructions For Author
【官网信息】
The Editorial Office is pleased to answer any questions you may have about preparing your manuscript in accordance with our guidelines.
Email: GSCM2023@126.com
AIMS AND SCOPE
Guidelines and Standards in Chinese Medicine (GSCM) is an international open access journal publishing peer-reviewed papers focusing on guidelines and standards-related studies of Chinese medicine, herbal medicine, acupuncture, moxibustion, homeopathy, complementary and integrative medicine, and others.
We particularly welcome studies including but not limited to:
Development and application of clinical practice guidelines, experts consensus, international/ national/ industry/ group/ standards;
Quality assessment of published clinical practice guidelines, experts consensus, international/ national/ industry/ group/ standards;
New tools/ methods/ methodological issues related to guidelines, consensus or standards;
We also welcome studies that could promote the development and application of guidelines and standards:
Design protocol, statistical analysis and reporting of clinical researches (randomized/ non-randomized controlled trials/ cohorts/ case-control studies/ case series/ case reports)
Basic science research using modern technology and method to explore the mechanism of the disease based on Chinese medicine, complementary and integrative medicine hypothesis and theory;
Pharmacy and pharmacology researches with focus on processing, extraction, identification and others to promote the innovation, modernization and application of herbal medicine;
Interdisciplinary studies, such as evidence-based public health policy and practice, medical-industrial crossover research.
We now publish original research and review papers. We may also publish opinion, perspective, letter to editors or short communications which are by invitation only.
ONLINE SUBMISSION
All manuscripts must be submitted online at: https://www.editorialmanager.com/GSCM/default2.aspx.
First-time users
Please click the Register button at https://www.editorialmanager.com/GSCM/default2.aspx. Upon successful registration, you will be sent an email providing your username and password. Save this information for future reference. Note: If you have received an email from us with an assigned username and password, or if you are a repeat user, do not register again. Once you have an assigned username and password, you do not have to re-register.
Authors
Please click the Login button from the menu at the top of the page and login to the system as an author. Submit your manuscript according to the author instructions. You will be able to track the process of your manuscript through the system.
JOURNAL POLICIES
DUPLICATE PUBLICATION
Manuscripts are reviewed for possible publication with the understanding that they are being submitted only to the Guidelines and Standards in Chinese Medicine and have not been published, simultaneously submitted, or already accepted for publication elsewhere. The Editorial team may subject any manuscript submitted for consideration of publication in Guidelines and Standards in Chinese Medicine to plagiarism-detection software.
This does not preclude consideration of a manuscript that has been rejected by another journal or a complete report that follows publication of preliminary findings elsewhere, usually in the form of an abstract. Copies of any possibly duplicate published material should be submitted with the manuscript under consideration, with a statement in the cover letter as to why the manuscript currently being submitted is not a duplicate publication.
DISCLOSURE OF CONFLICTS
Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript.
All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading "Conflicts of Interest” and “Source of Funding".
For example: “Conflicts of Interest: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker's bureau for Organization X - the CME organizers for Company A. For the remaining authors none were declared.”
“Source of Funding”: list all the grant supports/funders for the study.
A financial disclosure section is part of the submission process and must be completed by each author at first revision. This information is for review by the Editors but will be published if relevant to the content of the accepted manuscript.
The primary purpose of the disclosure section is to determine whether authors have received any commercial financial support that could create a conflict of interest. In addition to monetary interests, a potential for conflict of interest can exist whether or not an individual believes that a relationship (such as dual commitments, competing interests, or competing loyalties) affects his or her scientific judgment. Please review ICMJE Uniform Requirements for Manuscripts Submitted to Biomedical Journals at the following link: http://www.icmje.org/conflicts-of-interest.
Studies in humans and animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.
Authors describing studies involving animals must have consulted the ‘Animal Research: Reporting In Vivo Experiments’ (ARRIVE) 2.0 guidelines, developed by the NC3Rs to improve standards of reporting, ensuring that the data from animal experiments can be fully scrutinized and utilized. Articles reporting in vivo experiments must adhere to the ARRIVE Essential 10 checklist as a minimum, and we encourage authors to use the full ARRIVE 2.0 checklist. The relevant information outlined in these guidelines should be included in the appropriate section of the article.
...
更多详见：
https://journals.lww.com/gscm/Pages/Information-to-Authors.aspx
